Clinical trial
Phase 1 Trial of 3-2,4 Dimethoxbenzylidene Anabaseine in Schizophrenia
NCT00255918 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1 Trial of 3-2,4 Dimethoxbenzylidene Anabaseine in Schizophrenia
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 31, 2004
- Completion date
- October 31, 2005
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.